ASC-话题@MedSci

#ASC#

1352篇内容 | 3980人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1939492, encodeId=b257193949232, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：1型糖尿病患者心肌梗死后的长期心血管预后, objectType=article, longId=738821, objectId=789ee3882159, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=789ee3882159, replyNumber=0, likeNumber=98, createdTime=2022-09-21, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=789ee3882159, moduleTitle=Cardiovasc Diabetol：1型糖尿病患者心肌梗死后的长期心血管预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=789ee3882159)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939479, encodeId=3fc219394e97a, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：沙库巴曲缬沙坦钠片对糖尿病合并心力衰竭患者血糖的影响, objectType=article, longId=735928, objectId=063ee3592845, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=063ee3592845, replyNumber=0, likeNumber=93, createdTime=2023-06-21, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=063ee3592845, moduleTitle=Cardiovasc Diabetol：沙库巴曲缬沙坦钠片对糖尿病合并心力衰竭患者血糖的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=063ee3592845)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939330, encodeId=23671939330a5, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：这一部位脂肪越少，糖尿病患者发生心血管意外的风险越高！, objectType=article, longId=301173, objectId=450d3011e331, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=450d3011e331, replyNumber=0, likeNumber=63, createdTime=2022-12-09, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=450d3011e331, moduleTitle=Cardiovasc Diabetol：这一部位脂肪越少，糖尿病患者发生心血管意外的风险越高！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=450d3011e331)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939447, encodeId=046b193944e5c, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：1型糖尿病患者的动脉僵硬度及其与心血管风险评估工具的比较, objectType=article, longId=729723, objectId=a164e2972340, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a164e2972340, replyNumber=0, likeNumber=59, createdTime=2023-05-08, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a164e2972340, moduleTitle=Cardiovasc Diabetol：1型糖尿病患者的动脉僵硬度及其与心血管风险评估工具的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a164e2972340)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939365, encodeId=a32119393656e, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2022 ASCO：免疫治疗时代，原发灶不明的恶性黑色素瘤患者生存率得到改善, objectType=article, longId=728231, objectId=69a9e28231d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69a9e28231d1, replyNumber=0, likeNumber=86, createdTime=2022-11-10, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69a9e28231d1, moduleTitle=2022 ASCO：免疫治疗时代，原发灶不明的恶性黑色素瘤患者生存率得到改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69a9e28231d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939404, encodeId=eaa219394044d, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2022 ASCO：戈利昔替尼用于治疗难治性或复发性外周T细胞淋巴瘤的I期/II期研究, objectType=article, longId=728521, objectId=9843e28521fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9843e28521fc, replyNumber=0, likeNumber=69, createdTime=2023-03-21, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9843e28521fc, moduleTitle=2022 ASCO：戈利昔替尼用于治疗难治性或复发性外周T细胞淋巴瘤的I期/II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9843e28521fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939300, encodeId=b5471939300fa, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：在退伍军人糖尿病试验(VADT)中，低空腹c肽水平与心血管风险、随访时血糖变化和严重低血糖相关, objectType=article, longId=293433, objectId=affd2934339d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=affd2934339d, replyNumber=0, likeNumber=93, createdTime=2022-08-11, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=affd2934339d, moduleTitle=Cardiovasc Diabetol：在退伍军人糖尿病试验(VADT)中，低空腹c肽水平与心血管风险、随访时血糖变化和严重低血糖相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=affd2934339d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939428, encodeId=4f541939428f4, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2022：神经肿瘤领域重磅研究合集, objectType=article, longId=728829, objectId=17b8e28829df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17b8e28829df, replyNumber=0, likeNumber=60, createdTime=2023-04-30, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17b8e28829df, moduleTitle=ASCO 2022：神经肿瘤领域重磅研究合集, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17b8e28829df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939436, encodeId=3c731939436c7, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO2022 | TROPiCS-02临床重磅发布：戈沙妥珠单抗使HR+/HER2-MBC进展或死亡降低34%！, objectType=article, longId=728853, objectId=14b5e2885349, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14b5e2885349, replyNumber=0, likeNumber=90, createdTime=2023-05-01, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14b5e2885349, moduleTitle=ASCO2022 | TROPiCS-02临床重磅发布：戈沙妥珠单抗使HR+/HER2-MBC进展或死亡降低34%！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14b5e2885349)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939473, encodeId=b8cc19394e3a2, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：糖化ACE2可降低糖尿病患者心脏中RAS系统抑制的抗重构作用, objectType=article, longId=735303, objectId=ae19e3530333, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae19e3530333, replyNumber=0, likeNumber=115, createdTime=2023-06-28, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae19e3530333, moduleTitle=Cardiovasc Diabetol：糖化ACE2可降低糖尿病患者心脏中RAS系统抑制的抗重构作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae19e3530333)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939291, encodeId=2c241939291b1, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Journal of Vascular Surgery：血管钙化对腹主动脉瘤进展的预后影响, objectType=article, longId=292416, objectId=eb3329241686, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb3329241686, replyNumber=0, likeNumber=72, createdTime=2022-09-10, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb3329241686, moduleTitle=Journal of Vascular Surgery：血管钙化对腹主动脉瘤进展的预后影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb3329241686)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939427, encodeId=d4d9193942ed1, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=君实生物宣布icatolimab和特瑞普利单抗近40项研究成果在2022年美国临床肿瘤学会（ASCO）年会上公布, objectType=article, longId=728850, objectId=e55ee2885022, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e55ee2885022, replyNumber=0, likeNumber=94, createdTime=2022-10-17, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e55ee2885022, moduleTitle=君实生物宣布icatolimab和特瑞普利单抗近40项研究成果在2022年美国临床肿瘤学会（ASCO）年会上公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e55ee2885022)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939382, encodeId=22481939382c8, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2022 | 经历过胃癌手术的患者，代谢综合征和脂肪肝患病风险较低, objectType=article, longId=728448, objectId=ed2ee284484b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed2ee284484b, replyNumber=0, likeNumber=77, createdTime=2022-08-10, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed2ee284484b, moduleTitle=ASCO 2022 | 经历过胃癌手术的患者，代谢综合征和脂肪肝患病风险较低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed2ee284484b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939499, encodeId=66a71939499a7, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol ：预测2型糖尿病合并动脉粥样硬化性心血管疾病患者心血管死亡、非致命性心肌梗死或非致命性中风的模型的建立和验证, objectType=article, longId=739439, objectId=d119e394393a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d119e394393a, replyNumber=0, likeNumber=80, createdTime=2022-09-23, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d119e394393a, moduleTitle=Cardiovasc Diabetol ：预测2型糖尿病合并动脉粥样硬化性心血管疾病患者心血管死亡、非致命性心肌梗死或非致命性中风的模型的建立和验证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d119e394393a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939429, encodeId=0d71193942912, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2022 | ASCENT临床大胜收官：面对「老大难」mTNBC，戈沙妥珠单抗实现OS/PFS双获益！, objectType=article, longId=728854, objectId=1528e28854ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1528e28854ea, replyNumber=0, likeNumber=90, createdTime=2022-10-03, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1528e28854ea, moduleTitle=ASCO 2022 | ASCENT临床大胜收官：面对「老大难」mTNBC，戈沙妥珠单抗实现OS/PFS双获益！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1528e28854ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939450, encodeId=048d1939450bb, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=【即将直播】黄慧强：2022ASCO淋巴瘤研究进展解读, objectType=article, longId=730436, objectId=278fe30436dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=278fe30436dd, replyNumber=0, likeNumber=26, createdTime=2023-05-19, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=278fe30436dd, moduleTitle=【即将直播】黄慧强：2022ASCO淋巴瘤研究进展解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=278fe30436dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939343, encodeId=b159193934347, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：TyG指数可作为癌症幸存者心血管疾病风险分层的替代指标, objectType=article, longId=724678, objectId=7b02e2467887, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b02e2467887, replyNumber=0, likeNumber=73, createdTime=2022-12-19, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b02e2467887, moduleTitle=Cardiovasc Diabetol：TyG指数可作为癌症幸存者心血管疾病风险分层的替代指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b02e2467887)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939386, encodeId=7f3519393866e, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2022 ASCO：罗沙司他治疗非髓系恶性肿瘤化疗患者贫血的开放标签2期研究, objectType=article, longId=728449, objectId=5f21e284496f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f21e284496f, replyNumber=0, likeNumber=82, createdTime=2022-11-16, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f21e284496f, moduleTitle=2022 ASCO：罗沙司他治疗非髓系恶性肿瘤化疗患者贫血的开放标签2期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f21e284496f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939362, encodeId=abd71939362ee, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：2型糖尿病患者体重减轻程度和体重变异性与死亡率和主要心血管事件的关系, objectType=article, longId=727865, objectId=1076e2786521, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1076e2786521, replyNumber=0, likeNumber=89, createdTime=2023-03-19, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1076e2786521, moduleTitle=Cardiovasc Diabetol：2型糖尿病患者体重减轻程度和体重变异性与死亡率和主要心血管事件的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1076e2786521)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939433, encodeId=c4cd193943309, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2022 | FAKTION临床：capivasertib+氟维司群，改善芳香化酶抑制剂耐药MBC患者生存！, objectType=article, longId=729099, objectId=c01ae29099c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c01ae29099c1, replyNumber=0, likeNumber=85, createdTime=2023-01-05, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c01ae29099c1, moduleTitle=ASCO 2022 | FAKTION临床：capivasertib+氟维司群，改善芳香化酶抑制剂耐药MBC患者生存！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c01ae29099c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASC

2020-05-29

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：1型糖尿病患者心肌梗死后的长期心血管预后

2022-09-21

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：沙库巴曲缬沙坦钠片对糖尿病合并心力衰竭患者血糖的影响

2023-06-21

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：这一部位脂肪越少，糖尿病患者发生心血管意外的风险越高！

2022-12-09

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：1型糖尿病患者的动脉僵硬度及其与心血管风险评估工具的比较

2023-05-08

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2022 ASCO：免疫治疗时代，原发灶不明的恶性黑色素瘤患者生存率得到改善

2022-11-10

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2022 ASCO：戈利昔替尼用于治疗难治性或复发性外周T细胞淋巴瘤的I期/II期研究

2023-03-21

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：在退伍军人糖尿病试验(VADT)中，低空腹c肽水平与心血管风险、随访时血糖变化和严重低血糖相关

2022-08-11

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2022：神经肿瘤领域重磅研究合集

2023-04-30

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO2022 | TROPiCS-02临床重磅发布：戈沙妥珠单抗使HR+/HER2-MBC进展或死亡降低34%！

2023-05-01

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：糖化ACE2可降低糖尿病患者心脏中RAS系统抑制的抗重构作用

2023-06-28

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Journal of Vascular Surgery：血管钙化对腹主动脉瘤进展的预后影响

2022-09-10

quxin068 (审核中...)

前往app查看评论内容

#ASC#

君实生物宣布icatolimab和特瑞普利单抗近40项研究成果在2022年美国临床肿瘤学会（ASCO）年会上公布

2022-10-17

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2022 | 经历过胃癌手术的患者，代谢综合征和脂肪肝患病风险较低

2022-08-10

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol ：预测2型糖尿病合并动脉粥样硬化性心血管疾病患者心血管死亡、非致命性心肌梗死或非致命性中风的模型的建立和验证

2022-09-23

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2022 | ASCENT临床大胜收官：面对「老大难」mTNBC，戈沙妥珠单抗实现OS/PFS双获益！

2022-10-03

quxin068 (审核中...)

前往app查看评论内容

#ASC#

【即将直播】黄慧强：2022ASCO淋巴瘤研究进展解读

2023-05-19

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：TyG指数可作为癌症幸存者心血管疾病风险分层的替代指标

2022-12-19

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2022 ASCO：罗沙司他治疗非髓系恶性肿瘤化疗患者贫血的开放标签2期研究

2022-11-16

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：2型糖尿病患者体重减轻程度和体重变异性与死亡率和主要心血管事件的关系

2023-03-19

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2022 | FAKTION临床：capivasertib+氟维司群，改善芳香化酶抑制剂耐药MBC患者生存！

2023-01-05

科室
- - 订阅+
  - 更多科室
工具
服务